Entities / Company
Adaptive Biotechnologies.
company in Seattle, United States
- Reports this week
- 2
- Active events
- 1
- Connections
- 30
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
One to three months ago
Gone quiet
No new reports in 90+ days-
The FDA granted authorization for an Investigational Device Exemption (IDE) application involving Adaptive Biotechnologies.Some support1 report
-
Insider at Adaptive Biotechnologies sold shares of the company, disclosed via an SEC filing.Well supported4 reports
-
Adaptive Biotechnologies is evaluating strategic alternatives for its Immune Medicine segment.Some support1 report
-
Adaptive Biotechnologies and Genentech have terminated their strategic collaboration agreement.Some support2 reports
-
Adaptive Biotechnologies and NeoGenomics announced a strategic partnership on June 26, 2025.Speculative1 report
-
The FDA cleared a diagnostic test, with the involved companies being Adaptive Biotechnologies and Fortrea Holdings Inc.Speculative1 report
-
Aristotle Atlantic highlighted Adaptive Biotechnologies as a stock pick in a strategy report.Some support1 report
-
Adaptive Biotechnologies reported results and integrated its clonoSEQ technology into Flatiron’s OncoEMR platform.Some support3 reports
-
Adaptive Biotechnologies and Cardinal Health both outperformed their respective sectors in a report dated August 25, 2025.Some support2 reports
-
Adaptive Biotechnologies, a company, is based in Seattle, Washington.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Adaptive Biotechnologies this week
News at the entities that move Adaptive Biotechnologies most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Adaptive Biotechnologies
-
TD Cowen Mentioned togetherAnalyst downgraded Ag Growth International Inc. due to debt management risks.Moves Adaptive Biotechnologies
-
Morgan Stanley TransactionalFinancial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Moves Adaptive Biotechnologies
-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Adaptive Biotechnologies
-
Glasgow Shared contextCatherine Connolly visits Glasgow City Archives to research how Irish migration has shaped Scottish communities.Moves Adaptive Biotechnologies
-
Seattle Shared contextStatue buyers are considering both Portland and Seattle as potential locations for a new monument.Moves Adaptive Biotechnologies
Connections
The 7 strongest of 30, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Harlan Robins Transactional
Harlan Robins, identified as an insider, executed a sale of company shares related to Adaptive Biotechnologies.
-
FDA Structural
The company operates under the formal oversight and approval requirements of the FDA.
-
Morgan Stanley Transactional
Morgan Stanley formally raised its price target for Adaptive Biotechnologies.
-
SEC Structural
Adaptive Biotechnologies is subject to formal regulation by the SEC, as evidenced by required disclosures.
-
Glasgow Shared context
Adaptive Biotechnologies presented findings at a meeting held in the city of Glasgow.
-
TD Cowen Mentioned together
TD Cowen provides research reports on Adaptive Biotechnologies.
-
Seattle Shared context
Adaptive Biotechnologies is based and operates within the city of Seattle.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
2 eventsJune 2026
10 events- The FDA granted authorization for an Investigational Device Exemption (IDE) application involving Adaptive Biotechnologies.
- Insider at Adaptive Biotechnologies sold shares of the company, disclosed via an SEC filing.
- Adaptive Biotechnologies is evaluating strategic alternatives for its Immune Medicine segment.
- Adaptive Biotechnologies and Genentech have terminated their strategic collaboration agreement.
- Adaptive Biotechnologies and NeoGenomics announced a strategic partnership on June 26, 2025.
- The FDA cleared a diagnostic test, with the involved companies being Adaptive Biotechnologies and Fortrea Holdings Inc.
- Aristotle Atlantic highlighted Adaptive Biotechnologies as a stock pick in a strategy report.
- Adaptive Biotechnologies reported results and integrated its clonoSEQ technology into Flatiron’s OncoEMR platform.
- Adaptive Biotechnologies and Cardinal Health both outperformed their respective sectors in a report dated August 25, 2025.
- Adaptive Biotechnologies, a company, is based in Seattle, Washington.